echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Notice on the Public Solicitation of Opinions on the Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials

    Notice on the Public Solicitation of Opinions on the Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Notice on the Public Solicitation of Opinions on the Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials
    Release date: 20221008

    To further guide the assessment of the potential for drug-induced liver injury in clinical trials of drugs, to ensure the safety of subjects, and to obtain safety information to assess the risk characteristics


    We sincerely welcome all sectors of the community to put forward valuable comments and suggestions on the draft for comments, and timely feedback to us for follow-up improvement


    Please send your feedback to the email address of the following contact:

    Contact: Chen Ying, He Chunli

    Contact: cheny@cde.


    Thank you for your participation and great support


    Centre for Drug Evaluation

    October 8, 2022

    Related Attachments

    serial number The attachment name
    1 The Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials (Draft for Solicitation of Comments) .
    pdf
    2 The Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials .
    pdf drafted instructions
    3 The Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials .
    docx for Solicitation of Comments
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.